You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
DUCORD, derived from umbilical cord blood, has been approved for use in patients with disorders affecting the hematopoietic system — which produces the body’s blood cells —that are inherited, acquired or result from radiation treatment or chemotherapy.
Sir John B. Gurdon discovered that the specialization of cells is reversible when in a now-classic experiment conducted in 1962 he replaced the immature cell nucleus in a frog's egg cell with the nucleus of a mature intestinal cell. The modified cell developed into a normal tadpole.
However this solution is at best temporary and alleviates none of the patient's pain; in fact, when the graft fails the patient often experiences an increase in suffering. This has left the medical world searching for a long-term solution to deal with the disease in a sustained way.